Articular ¹⁸Fluorodeoxyglucose Uptake Is Associated With Clinically Assessed Swollen Joint Count in Patients With Rheumatoid Arthritis

Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award number AR-050026 [JMB]), and by the National Institutes of Health (NIH) National Center for Translational Science Clinical and Translational Science Award (CTSA grant UL1 TR000040), and by the Rheumatology Research Foundation (award number RHEUMARF CU12-3892). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I. Ferraz-Amaro, MD, Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain; A. Sheikh, MD, Department of Radiology, Division of Nuclear Medicine, Kettering Health, Dayton, Ohio, USA; B. Polack, MD, Visiting Professor, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; J.T. Giles, MD, J.M. Bathon, MD, Division of Rheumatology, Department of Medicine, Columbia University College of Physicans and Surgeons, New York, New York, USA. BP is currently Head of Medical Information, Global Medical Affairs, Advanced Accelerator Applications, a Novartis Company. Her contribution to this work was performed while a Visiting Professor in Radiology at Columbia University. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I. Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain. Email: iferrazamaro@hotmail.com. Accepted for publication July 22, 2022.

Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award number AR-050026 [JMB]), and by the National Institutes of Health (NIH) National Center for Translational Science Clinical and Translational Science Award (CTSA grant UL1 TR000040), and by the Rheumatology Research Foundation (award number RHEUMARF CU12-3892). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I. Ferraz-Amaro, MD, Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain; A. Sheikh, MD, Department of Radiology, Division of Nuclear Medicine, Kettering Health, Dayton, Ohio, USA; B. Polack, MD, Visiting Professor, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; J.T. Giles, MD, J.M. Bathon, MD, Division of Rheumatology, Department of Medicine, Columbia University College of Physicans and Surgeons, New York, New York, USA. BP is currently Head of Medical Information, Global Medical Affairs, Advanced Accelerator Applications, a Novartis Company. Her contribution to this work was performed while a Visiting Professor in Radiology at Columbia University. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I. Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain. Email: iferrazamaro@hotmail.com. Accepted for publication July 22, 2022.

Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award number AR-050026 [JMB]), and by the National Institutes of Health (NIH) National Center for Translational Science Clinical and Translational Science Award (CTSA grant UL1 TR000040), and by the Rheumatology Research Foundation (award number RHEUMARF CU12-3892). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I. Ferraz-Amaro, MD, Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain; A. Sheikh, MD, Department of Radiology, Division of Nuclear Medicine, Kettering Health, Dayton, Ohio, USA; B. Polack, MD, Visiting Professor, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; J.T. Giles, MD, J.M. Bathon, MD, Division of Rheumatology, Department of Medicine, Columbia University College of Physicans and Surgeons, New York, New York, USA. BP is currently Head of Medical Information, Global Medical Affairs, Advanced Accelerator Applications, a Novartis Company. Her contribution to this work was performed while a Visiting Professor in Radiology at Columbia University. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I. Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain. Email: iferrazamaro@hotmail.com. Accepted for publication July 22, 2022.

Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award number AR-050026 [JMB]), and by the National Institutes of Health (NIH) National Center for Translational Science Clinical and Translational Science Award (CTSA grant UL1 TR000040), and by the Rheumatology Research Foundation (award number RHEUMARF CU12-3892). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I. Ferraz-Amaro, MD, Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain; A. Sheikh, MD, Department of Radiology, Division of Nuclear Medicine, Kettering Health, Dayton, Ohio, USA; B. Polack, MD, Visiting Professor, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; J.T. Giles, MD, J.M. Bathon, MD, Division of Rheumatology, Department of Medicine, Columbia University College of Physicans and Surgeons, New York, New York, USA. BP is currently Head of Medical Information, Global Medical Affairs, Advanced Accelerator Applications, a Novartis Company. Her contribution to this work was performed while a Visiting Professor in Radiology at Columbia University. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I. Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain. Email: iferrazamaro@hotmail.com. Accepted for publication July 22, 2022.

Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award number AR-050026 [JMB]), and by the National Institutes of Health (NIH) National Center for Translational Science Clinical and Translational Science Award (CTSA grant UL1 TR000040), and by the Rheumatology Research Foundation (award number RHEUMARF CU12-3892). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I. Ferraz-Amaro, MD, Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain; A. Sheikh, MD, Department of Radiology, Division of Nuclear Medicine, Kettering Health, Dayton, Ohio, USA; B. Polack, MD, Visiting Professor, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; J.T. Giles, MD, J.M. Bathon, MD, Division of Rheumatology, Department of Medicine, Columbia University College of Physicans and Surgeons, New York, New York, USA. BP is currently Head of Medical Information, Global Medical Affairs, Advanced Accelerator Applications, a Novartis Company. Her contribution to this work was performed while a Visiting Professor in Radiology at Columbia University. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I. Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain. Email: iferrazamaro@hotmail.com. Accepted for publication July 22, 2022.